<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">FNS</journal-id><journal-title-group><journal-title>Food and Nutrition Sciences</journal-title></journal-title-group><issn pub-type="epub">2157-944X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/fns.2015.617166</article-id><article-id pub-id-type="publisher-id">FNS-62148</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Creating Benefits from Omega-3 Functional Foods and Nutraceuticals
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>atharine</surname><given-names>Clark</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bill</surname><given-names>Lands</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Clark Consulting and Coaching, Frederick, USA</addr-line></aff><aff id="aff2"><addr-line>American Society for Nutrition, College Park, USA</addr-line></aff><pub-date pub-type="epub"><day>23</day><month>12</month><year>2015</year></pub-date><volume>06</volume><issue>17</issue><fpage>1613</fpage><lpage>1623</lpage><history><date date-type="received"><day>26</day>	<month>October</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>20</month>	<year>December</year>	</date><date date-type="accepted"><day>23</day>	<month>December</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Foods currently eaten by Americans have abundant amounts of essential omega-6 (n-6) nutrients and relatively few omega-3 (n-3) nutrients. The average omega 3 - 6 balance score of typical US foods is about 
  –6. This imbalance causes the average American to accumulate tissue proportions of n-3 and n-6 highly unsaturated fatty acids (HUFA) with about 77% n-6 in HUFA. This HUFA balance links to many chronic health conditions that are made worse by overabundant actions of food-based omega-6 HUFA. Americans currently spend more on treating food-based health conditions than they spend on food. Less medication is needed to treat signs and symptoms when a key dietary cause of the signs and symptoms is prevented. Informed food producers can readily prepare and market new food products with more n-3 and less n-6 nutrients to reverse the current national nutrient imbalance and help people attain and maintain a healthy HUFA balance. New functional foods and nutraceuticals will help consumers shift their financial resources from treating signs and symptoms caused by HUFA imbalance to preventing the nutrient imbalance that causes the need to treat.
 
</p></abstract><kwd-group><kwd>Eicosanoids</kwd><kwd> Highly Unsaturated Fatty Acids (HUFA)</kwd><kwd> Inflammation</kwd><kwd> Omega-3 (n-3) Fatty Acid</kwd><kwd> Omega-6 (n-6) Fatty Acid</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Essential fatty acids (EFA) are vitamin-like nutrients needed for healthy human physiology. The 18-carbon polyunsaturated omega-3 (n-3) α-linolenic acid and omega-6 (n-6) linoleic acid are abundant in foliage and leafy vegetables, such as spinach, broccoli and cauliflower. When eaten, the n-3 nutrients compete with n-6 nutrients for metabolism to longer more highly unsaturated fatty acids (HUFA) which accumulate in the phospholipids of tissue membranes. A competitive hyperbolic equation [<xref ref-type="bibr" rid="scirp.62148-ref1">1</xref>] describes the diet-tissue relationship by which the EFA in foods maintain proportions of n-3 and n-6 HUFA in human tissues. The current average EFA intakes in US foods have an omega 3 - 6 balance score near-6, whereas traditional Mediterranean foods averaged near −3 and traditional Japanese foods averaged near +2 [<xref ref-type="bibr" rid="scirp.62148-ref2">2</xref>] . These average scores maintain tissue HUFA balances near 75%, 60%, and 40% n-6 in HUFA, respectively. Measurements obtained from apparently healthy people with different traditional food habits range from 25% to 85% n-6 in HUFA. The %n-6 in HUFA is an objective measure of n-3 and n-6 nutrient intakes [<xref ref-type="bibr" rid="scirp.62148-ref2">2</xref>] .</p><p>The HUFA balance predictably linked to average EFA intakes is also associated with a risk for chronic inflammatory disorders [<xref ref-type="bibr" rid="scirp.62148-ref3">3</xref>] . People with more than 50% n-6 in HUFA have a greater risk of death from cardiovascular disease (CVD) than people with less than 50% n-6 in HUFA. Mechanisms for the CVD pathophysiology include conversion of the n-6 HUFA, arachidonic acid, into powerful inflammatory hormone-like eicosanoids that amplify events in vascular inflammatory atherosclerosis and fatal thrombosis [<xref ref-type="bibr" rid="scirp.62148-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref5">5</xref>] . In the absence of dietary n-3 nutrients, intakes of n-6 linoleic acid as low as 0.4 percent of food energy (0.4 en%) can give 50% n-6 in HUFA. Eating less may lead to EFA deficiency, and eating more may increase the risk for excessive n-6 HUFA actions. Thus, dietary n-6 linoleate has a very narrow therapeutic window [<xref ref-type="bibr" rid="scirp.62148-ref4">4</xref>] . An important action of dietary n-3 nutrients is to raise the proportion of n-3 in tissue HUFA and to widen the range of n-6 intake that has a low risk of excessive n-6 HUFA action.</p><p>Plant foods common in tropical Africa during early human evolution likely had omega 3 - 6 balance scores near 0, like leafy foliage (0), cassava (−0.1), sweet potato (−0.5), yam (−0.4), plantain (−0.1) and taro (−3) [<xref ref-type="bibr" rid="scirp.62148-ref6">6</xref>] . Over time, people in central and western Africa selectively acquired a genetic haplotype which has faster Δ6 and Δ5 desaturation activity [<xref ref-type="bibr" rid="scirp.62148-ref7">7</xref>] . That gave faster conversion of dietary n-3 and n-6 PUFA to tissue HUFA and ensured supplies of n-3 and n-6 HUFA adequate for human brain and retinal function during rapid infant development. However, it now makes many African-Americans more responsive than Caucasians or Asians to the very high amounts of n-6 linoleate from food oils in the current American diet (7 en%, rather than the 0.4 en% that prevents EFA deficiency). The consequence is a greater tendency for a higher % n-6 in HUFA and for more unwanted chronic inflammatory disorders. African-Americans have higher prevalence of chronic disease including: cardiovascular disease, hypertension, colorectal cancer, obesity, asthma, and periodontitis [<xref ref-type="bibr" rid="scirp.62148-ref8">8</xref>] . In fact, the prevalence of type 2 diabetes (insulin resistance) is nearly twice as high among African-American adults compared to white adults [<xref ref-type="bibr" rid="scirp.62148-ref8">8</xref>] .</p></sec><sec id="s2"><title>2. Multiple Chronic Conditions Are Becoming Financially Unsustainable</title><p>The general status of health and wellness (or its counterpart, sickness and death) can be described in many ways. For example, the US economy currently allocates more financial resources to healthcare than to food, and food- based imbalances cause the high need for healthcare [<xref ref-type="bibr" rid="scirp.62148-ref9">9</xref>] . The Centers for Disease Control and Prevention (CDC) estimated that chronic health conditions―such as heart disease, stroke, cancer, diabetes, obesity, and arthritis―are among the most common, costly, and preventable of all health problems [<xref ref-type="bibr" rid="scirp.62148-ref10">10</xref>] . Eighty six percent (86%) of healthcare spending is for chronic medical conditions [<xref ref-type="bibr" rid="scirp.62148-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref11">11</xref>] . The US will likely spend $2.7 trillion treating chronic diseases in 2015 (<xref ref-type="table" rid="table1">Table 1</xref>)―much of which is considered preventable. This is more than total healthcare spending in 2010. The US needs to change its foods.</p><p>The US healthcare system is focused on discovering treatments rather than preventing chronic disease [<xref ref-type="bibr" rid="scirp.62148-ref16">16</xref>] . While medications are profitable (and sometimes a useful interim step), they can have undesired side effects,</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Cost of chronic health conditions</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Year</th><th align="center" valign="middle" >Healthcare Spending($)</th><th align="center" valign="middle" >% of GDP</th><th align="center" valign="middle" >Healthcare (Avg $/person)</th><th align="center" valign="middle" >Chronic Disease Prevalence</th><th align="center" valign="middle" >Chronic Disease Spending ($)</th><th align="center" valign="middle" >Chronic Disease (Avg $/person)</th></tr></thead><tr><td align="center" valign="middle" >2000</td><td align="center" valign="middle" >1.4T [<xref ref-type="bibr" rid="scirp.62148-ref12">12</xref>]</td><td align="center" valign="middle" >13.8 [<xref ref-type="bibr" rid="scirp.62148-ref14">14</xref>]</td><td align="center" valign="middle" >4,878 [<xref ref-type="bibr" rid="scirp.62148-ref14">14</xref>]</td><td align="center" valign="middle" >70% [<xref ref-type="bibr" rid="scirp.62148-ref15">15</xref>]</td><td align="center" valign="middle" >1.0T</td><td align="center" valign="middle" >3,415</td></tr><tr><td align="center" valign="middle" >2005</td><td align="center" valign="middle" >2.0T [<xref ref-type="bibr" rid="scirp.62148-ref12">12</xref>]</td><td align="center" valign="middle" >16.1 [<xref ref-type="bibr" rid="scirp.62148-ref14">14</xref>]</td><td align="center" valign="middle" >6,868 [<xref ref-type="bibr" rid="scirp.62148-ref14">14</xref>]</td><td align="center" valign="middle" >75% [<xref ref-type="bibr" rid="scirp.62148-ref16">16</xref>]</td><td align="center" valign="middle" >1.5T</td><td align="center" valign="middle" >5,151</td></tr><tr><td align="center" valign="middle" >2010</td><td align="center" valign="middle" >2.6T [<xref ref-type="bibr" rid="scirp.62148-ref12">12</xref>]</td><td align="center" valign="middle" >17.9 [<xref ref-type="bibr" rid="scirp.62148-ref14">14</xref>]</td><td align="center" valign="middle" >8,402 [<xref ref-type="bibr" rid="scirp.62148-ref14">14</xref>]</td><td align="center" valign="middle" >86% [<xref ref-type="bibr" rid="scirp.62148-ref11">11</xref>]</td><td align="center" valign="middle" >2.2T</td><td align="center" valign="middle" >7,226</td></tr><tr><td align="center" valign="middle" >2015</td><td align="center" valign="middle" >3.1T [<xref ref-type="bibr" rid="scirp.62148-ref13">13</xref>]</td><td align="center" valign="middle" >18.0 [<xref ref-type="bibr" rid="scirp.62148-ref13">13</xref>]</td><td align="center" valign="middle" >10,125 [<xref ref-type="bibr" rid="scirp.62148-ref13">13</xref>]</td><td align="center" valign="middle" >86% [<xref ref-type="bibr" rid="scirp.62148-ref11">11</xref>]</td><td align="center" valign="middle" >2.7T</td><td align="center" valign="middle" >8,708</td></tr></tbody></table></table-wrap><p>and their continued use is needed when the food-based cause remains unaddressed. Translating knowledge of risk factor mechanisms into effective informed preventive nutrition actions is an important step toward preventing costly, chronic conditions resulting from food-based mediators [<xref ref-type="bibr" rid="scirp.62148-ref9">9</xref>] .</p><p>Heart disease, obesity, and type-2 diabetes are at epidemic levels in the US, and they have well-documented food-based n-6 mediators [<xref ref-type="bibr" rid="scirp.62148-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref5">5</xref>] . Depression is another epidemic condition not yet recognized by the public to associate with HUFA balance [<xref ref-type="bibr" rid="scirp.62148-ref17">17</xref>] . Chronic disease and depression are mutually reinforcing: chronic disease can exacerbate depression, while depression can lead to chronic disease [<xref ref-type="bibr" rid="scirp.62148-ref16">16</xref>] . Pharmaceutical companies know imbalanced actions of n-6 mediators for which they produce and market many medications to mitigate food-based pathophysiology. Food producers and manufacturers are becoming aware of their opportunity to significantly alter food-based pathophysiology. Their actions in making better-balanced foods available can shift current health conditions toward increased wellness for the public.</p><p>Understanding the causal links between foods and food-based health conditions allows deliberate, explicit implementation of effective preventive nutrition programs [<xref ref-type="bibr" rid="scirp.62148-ref9">9</xref>] . When people increase their intake of n-3 nutrients while decreasing excess n-6 nutrients, they lower the health risk assessment (HRA) biomarker, the %n-6 in HUFA. Effective preventive nutrition addressing the root causes of chronic diseases can benefit the US economy. In 2015, the US will spend 86% of its $3.1 trillion healthcare resources treating chronic diseases. Among the most prevalent chronic conditions, allergies rank #3 and asthma ranks #8 for adults, whereas for children, asthma and allergies rank #1 and #2, respectively [<xref ref-type="bibr" rid="scirp.62148-ref11">11</xref>] . Allergies are a major trigger for asthma. In addition, chronic obstructive lung disease and bronchiectasis are ranked #11 in prevalence for adults, and chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the US [<xref ref-type="bibr" rid="scirp.62148-ref18">18</xref>] . A common aspect of all these immune-inflammatory disorders is excessive action of n-6 eicosanoids derived from an over-abundant intake of n-6 nutrients.</p><p>The eicosanoids are potent signaling molecules, and n-3 and n-6 eicosanoids act at selective receptor sites in nearly every tissue of the human body [<xref ref-type="bibr" rid="scirp.62148-ref5">5</xref>] . The cysteinyl leukotriene eicosanoids are potent bronchoconstrictors formed by 5-lipoxygenase and leukotriene C synthase after phospholipase releases the n-3 and n-6 HUFA precursors from tissue membrane phospholipids [<xref ref-type="bibr" rid="scirp.62148-ref19">19</xref>] . Both n-3 and n-6 leukotrienes can increase bronchopulmonary distress in asthma and COPD, however formation of n-6 LTC<sub>4</sub> is more intense than n-3 LTC<sub>5</sub> [<xref ref-type="bibr" rid="scirp.62148-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref21">21</xref>] . A major contributor to recruiting leukocytes that amplify inflammatory conditions is the vigorous chemotactic response of the BLT1 receptor with n-6 LTB<sub>4</sub>. It is 100-fold greater than the response with n-3 LTB<sub>5</sub> [<xref ref-type="bibr" rid="scirp.62148-ref22">22</xref>] . Inflammation is amplified as food-based n-6 LTB<sub>4 </sub>attracts more leukocytes to an area and signals for release of chemokines (a protein activating additional white blood cells).</p><p>Macrophages play a key role in the pathophysiology of obesity-induced insulin resistance. These inflammatory cells accumulate in crown-like structures around adipocytes [<xref ref-type="bibr" rid="scirp.62148-ref23">23</xref>] , and become a significant portion (up to 40% [<xref ref-type="bibr" rid="scirp.62148-ref24">24</xref>] ) of the cells in obese adipose tissue. Macrophages release cytokines and LTB<sub>4</sub> that recruit more inflammatory cells as adipose tissue develops systemic inflammatory characteristics [<xref ref-type="bibr" rid="scirp.62148-ref23">23</xref>] . LTB<sub>4</sub> acting through the BLT1 receptor directly induces inflammation and insulin resistance [<xref ref-type="bibr" rid="scirp.62148-ref24">24</xref>] . Genetically altered mice missing the BLT1 receptor were protected from glucose intolerance and insulin resistance [<xref ref-type="bibr" rid="scirp.62148-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref25">25</xref>] . Inhibition of LTB<sub>4</sub> could be a future goal for pharmaceutical treatment of insulin-resistance. Conversely, with n-6 LTB<sub>4</sub> actions on BLT1 being 100-fold greater than n-3 LTB<sub>5</sub> [<xref ref-type="bibr" rid="scirp.62148-ref22">22</xref>] , a promising form of primary prevention is reducing dietary n-6 and increasing the intake of n-3 functional foods. Informed food choices can likely decrease obesity, inflammation, and insulin resistance and have fewer side effects than medications or surgical procedures.</p><p>The obesity epidemic in the US has not been resolved by the multi-billion dollar weight-loss industry. Now categorized as a disease, obesity and its associated inflammatory processes play key roles in a complex chain of events linked to n-6 nutrients. The endocannabinoid system regulates food intake mediated by products of n-6 linoleic acid (LA) [<xref ref-type="bibr" rid="scirp.62148-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref27">27</xref>] . Elevated endocannabinoids increase weight gain while adipocytes become larger and adipose tissue more inflamed with macrophage infiltration [<xref ref-type="bibr" rid="scirp.62148-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref28">28</xref>] . Balancing weight-promoting n-6 nutrients with n-3 nutrients normalized endocannabinoid tone and body mass. That approach merits careful attention in preventing undesired appetitive behaviors and in maintaining food energy balance.</p><p>The large multi-year Look AHEAD clinical trial hypothesized that obesity is a valid surrogate for cardiovascular disease (CVD) [<xref ref-type="bibr" rid="scirp.62148-ref29">29</xref>] , the #1 cause of death in the US for many decades. The trial lowered the average body mass of 5145 overweight or obese participants with intent to reduce non-fatal myocardial infarction, hospitalized angina, and non-fatal stroke [<xref ref-type="bibr" rid="scirp.62148-ref29">29</xref>] . However, following successful weight reduction and increased physical activity, the trial was stopped after nearly 10 years because the hypothesis was not supported [<xref ref-type="bibr" rid="scirp.62148-ref29">29</xref>] . Obesity is an associative, predictive risk factor of CVD; it is not a valid surrogate. The health risk assessment factor, %n-6 in HUFA, has a high correlation with CVD and a causal mechanistic basis [<xref ref-type="bibr" rid="scirp.62148-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref30">30</xref>] . When people examine blood samples from the Look AHEAD participants, they may find an association between %n-6 in HUFA and CVD mortality and morbidity. This would redirect attention toward a more effective preventive nutrition strategy of lowering n-6 intakes and raising n-3 intakes.</p><p>As populations shifted from their traditional dietary patterns toward modern Western food habits, they experienced increased prevalence of deaths from chronic disease. One example is the increased deaths from prostate cancer in Japan and Italy [<xref ref-type="bibr" rid="scirp.62148-ref31">31</xref>] . Japanese historically had seafood as a dietary staple, a low %n-6 in HUFA as an objective biochemical outcome, and one of the lowest rates of prostate cancer deaths in the world. As the average %n-6 in HUFA increased from ~35% to 50%, prostate cancer deaths of elderly Japanese rose from 40 to 400 per 100,000 population. In Italy, where a traditional Mediterranean diet was typical in 1970, deaths from prostate cancer were near 250 per 100,000. However, over the next 30 years, as dietary habits became Westernized, the death rate doubled to 500 [<xref ref-type="bibr" rid="scirp.62148-ref31">31</xref>] . During this period prostate cancer deaths of elderly men in UK, France, and US remained near 500 to 600 per 100,000. In the US, it is the 5<sup>th</sup> leading cause of cancer death [<xref ref-type="bibr" rid="scirp.62148-ref32">32</xref>] . In 2015, there will likely be 220,000 new cases and 27,000 prostate cancers deaths in the US, with higher prevalence and deaths among African Americans [<xref ref-type="bibr" rid="scirp.62148-ref32">32</xref>] . Reducing the dietary intake of n-6 nutrients enables increased n-3 intakes to competitively attenuate actions of the n-6 thromboxane, TXA<sub>2</sub>, in facilitating cancer growth [<xref ref-type="bibr" rid="scirp.62148-ref33">33</xref>] .</p><p>There is no shortage of peer-reviewed studies listed by PubMed detailing mechanisms by which the innate immune system is amplified by n-6 actions. Thousands of these studies specify the eicosanoids involved (e.g., LTB<sub>4</sub>, TXA<sub>2</sub>, PGE<sub>2</sub>, PGF<sub>2α</sub>, PGI<sub>2</sub>). However, there is a shortage of information about which foods cause major imbalances in n-3 and n-6 nutrient intakes. Useful for this purpose are the omega 3-6 balance scores derived from eleven different n-3 and n-6 fatty acids based on information in the USDA Nutrient Database [<xref ref-type="bibr" rid="scirp.62148-ref2">2</xref>] . The scores predict the impact of a food item on the HRA biomarker, %n-6 in HUFA. Balance scores have dimensions of milligrams per Calorie (mg/kcal), and the negative and positive values combine together to give a predicted biomedical outcome for the %n-6 in HUFA. As consumers combine current food items with functional foods that have more positive (less negative) scores, the incremental differences add together, and can significantly shift the %n-6 in HUFA and clinically relevant outcomes in as little as 3 months [<xref ref-type="bibr" rid="scirp.62148-ref34">34</xref>] . This is important as food producers and marketers begin to resolve the current preventable epidemics.</p></sec><sec id="s3"><title>3. Address the Cause Not Just the Symptoms</title><p>Many medications relieve signs and symptoms of food-based chronic conditions. For example, low-dose aspirin decreases the actions of excessive n-6 thromboxane, TXA<sub>2</sub>, in blood platelets [<xref ref-type="bibr" rid="scirp.62148-ref5">5</xref>] . However, when the dietary imbalance causing their food-based condition has not been prevented, consumers need continual medication. This fits a profitable business model for pharmaceutical companies and manufacturers of over-the-counter medications. However, some question the benefit of treating signs and symptoms while leaving the food-based imbalance to cause additional harm [<xref ref-type="bibr" rid="scirp.62148-ref3">3</xref>] . Significant increases in chronic disease spending per person are likely to continue in the absence of effective preventive nutrition (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Creating functional foods and promoting new food choices is not in business plans of pharmaceutical companies or manufacturers of over the counter drugs. Moreover, if the CDC is correct that the US healthcare system “is not designed to prevent chronic diseases” and “has primarily focused on discovering [new] treatments” [<xref ref-type="bibr" rid="scirp.62148-ref16">16</xref>] , then the healthcare system is financially unsustainable and needs redesigning. Re-allocating $2.7T/year toward preventive nutrition may be sufficient financial incentive to motivate action [<xref ref-type="bibr" rid="scirp.62148-ref9">9</xref>] . Tools and apps are now available [<xref ref-type="bibr" rid="scirp.62148-ref35">35</xref>] to use the known competitive, hyperbolic diet-tissue relationship among EFA [<xref ref-type="bibr" rid="scirp.62148-ref1">1</xref>] and design new functional foods and nutraceuticals for better nutrient balance and health outcomes for consumers. The empirical equation quantitatively describes how lowering n-6 nutrient intake makes n-3 nutrients more effective in creating balanced HRA biomarker values. The concept of Omega Balance [<xref ref-type="bibr" rid="scirp.62148-ref36">36</xref>] addresses the current nutritional cause for many signs and symptoms, and new functional foods with high positive scores will not have adverse side effects seen with current medications. Informed preventive nutrition offers positive outcomes with lower cost.</p><p>To examine the benefit of a better HUFA balance, a recent randomized clinical trial on severe chronic headache pain designed two diets quite different from typical American diets in having much lower amounts of n-6 LA [<xref ref-type="bibr" rid="scirp.62148-ref34">34</xref>] . The low-n-6 diet (L6) replaced high-LA foods with low-LA foods. Adding n-3 nutrients to that diet gave a high n-3, low n-6 diet (H3-L6). During the 3-month clinical trial, the L6 diet gave a significant reduction</p><p>of pain in three objective clinical measures as patients’ HRA values went from 78% n-6 in HUFA to 75%n-6 in HUFA. More importantly, the H3-L6 group changed their average %n-6 in HUFA from 77% to 61% and experienced progressive reduction in pain during 3 months, a 40% lower need for medications, and an increased quality of life [<xref ref-type="bibr" rid="scirp.62148-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref37">37</xref>] .</p><p>This clinical trial demonstrated how rapidly an informed selection of foods can change the HUFA balance and its physiological consequences. The authors noted that more improvement in psychological distress may occur if the intervention was longer [<xref ref-type="bibr" rid="scirp.62148-ref37">37</xref>] . Also, individuals with an aversion to seafood were not fully compliant, and use of n-3 supplements may further improve outcomes [<xref ref-type="bibr" rid="scirp.62148-ref38">38</xref>] . Supplemental nutraceutical n-3 is a constructive alternative to improve HRA biomarkers in an open free-living population setting. In all scenarios with added n-3 nutrients, reducing dietary n-6 intake ensures more positive outcomes on objective and subjective measures of health, and a decreased need for medication in chronic conditions [<xref ref-type="bibr" rid="scirp.62148-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref37">37</xref>] .</p></sec><sec id="s4"><title>4. Creating Functional Foods</title><p>Investigators developing diets to give a better tissue HUFA balance replaced high-LA oils with macadamia-oil- vinaigrette salad dressing, and used fat-free mayonnaise [<xref ref-type="bibr" rid="scirp.62148-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref39">39</xref>] . Including fatty seafood rich in n-3 HUFA (e.g. wild salmon, trout, tuna, and sardines) plus functional foods created with flax meal (i.e., ground flax seeds) can provide more n-3 nutrients. Easily arranged recipes for muffins, granola, and bean dip create new functional foods by adding flax meal [<xref ref-type="bibr" rid="scirp.62148-ref38">38</xref>] . In considering a better tissue HUFA balance, the Department of Defense (DoD) noted a substantially increased cognitive load on the warfighter produced a need for better protection and recovery from wounds [<xref ref-type="bibr" rid="scirp.62148-ref40">40</xref>] . However, the current diet for active duty military personnel is imbalanced in n-3 and n-6 nutrients, as it resembles the standard American diet [<xref ref-type="bibr" rid="scirp.62148-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref40">40</xref>] [<xref ref-type="bibr" rid="scirp.62148-ref41">41</xref>] . Assessment of 287 active-duty soldiers showed an average 81% n-6 in HUFA [<xref ref-type="bibr" rid="scirp.62148-ref42">42</xref>] . The DoD concluded that restoring omega-3 fatty acids to optimal levels may improve performance and restore impaired personnel to healthy fit status. To sustain US leadership, DoD established goals for 2030 as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref> [<xref ref-type="bibr" rid="scirp.62148-ref40">40</xref>] .</p><p>Sample garrison foods were analyzed using the empirical equation noted in the Introduction [<xref ref-type="bibr" rid="scirp.62148-ref1">1</xref>] . They predicted an average value of 78% n-6 in HUFA [<xref ref-type="bibr" rid="scirp.62148-ref41">41</xref>] . Substituting n-3 rich foods, increasing low n-6 variants, and replacing high-LA with low-LA oils resulted in a substantial observed change in the %n-6 in HUFA, thus shifting</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Balance of n-3 in HUFA related to optimal health and force effectiveness. Omega Balance is expressed as %n-3 in HUFA. U.S. Military Active Duty is shown as 17% n-3 in HUFA (i.e., 83% n-6 in HUFA) and optimal health is considered 60% - 70% n-3 in HUFA. Reprinted from Defense Science Board ([<xref ref-type="bibr" rid="scirp.62148-ref40">40</xref>] , p. 57)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-2701750x6.png"/></fig><p>dietary patterns of active duty warfighters away from traditional nutrition guidelines [<xref ref-type="bibr" rid="scirp.62148-ref41">41</xref>] and current public advice from the Food and Nutrition Board [<xref ref-type="bibr" rid="scirp.62148-ref4">4</xref>] . The DoD implemented their decision by engaging food producers to assemble functional foods for garrison menus. Results presented in March 2015 during a public lecture showcased functional foods that DoD cooperatively developed with several food companies: Vital Choice, Smartfish, Omega Foods, DuPont, Belovo, and Aidells Sausage Company. New food items included salad dressings using low n-6 soybean oil [<xref ref-type="bibr" rid="scirp.62148-ref43">43</xref>] plus n-3 enriched chicken, eggs and fruit beverages. Researchers noted that lowering dietary n-6 in combination with elevating n-3 acts more potently to lower tissue n-6 HUFA balance than either approach alone [<xref ref-type="bibr" rid="scirp.62148-ref41">41</xref>] . Food producers play a positive role in helping the DoD move toward its goal of resilient warfighters with 40% - 50% n-6 in HUFA. There is much more they can do to expand markets to the broader public.</p><p>The Department of Agriculture (USDA) supported development of new peanut cultivars that can be useful as functional foods. Researchers in Florida, Georgia, North Carolina, Oklahoma, Texas and the UK [<xref ref-type="bibr" rid="scirp.62148-ref44">44</xref>] -[<xref ref-type="bibr" rid="scirp.62148-ref47">47</xref>] described new varieties that can replace staples in the American diet. Currently, peanuts, peanut butter, and peanut oil contain large amounts of n-6 have omega 3 - 6 balance scores of −26, −24, and −36, respectively [<xref ref-type="bibr" rid="scirp.62148-ref35">35</xref>] . Variants with less n-6 and much more monounsaturated oleic acid can be effective functional foods. In addition to having improved Omega Balance scores, low-linoleate products have greater shelf life. For many years the fats and oils industry handled low n-6 food oils from coconut or macadamia or from selected cultivars of sunflower, soybean, safflower, and canola which are not yet widely marketed to the public. These oils can be excellent starting points for developing new functional foods to improve the HUFA balance in consumers.</p><p>Many nutrition advisors recommend using foods rather than supplements to achieve dietary goals, yet few give consumers explicit data on the amounts of n-3 and n-6 nutrients in foods. Individuals can find information on how to create their own balance of n-3 and n-6 nutrients by downloading the Omega Meals tool onto their personal computer [<xref ref-type="bibr" rid="scirp.62148-ref35">35</xref>] . A simple example is converting snack pretzels (1 ounce (oz), 103 kcal, score = −2.1) into a functional food by combining it with flax oil (3 teaspoons (tsp), 120 kcal, score = +46). The Omega Meals tool combines the data and shows the resulting 223 kcal snack has an omega 3 - 6 balance score of +24.2 which has a very good impact on a person’s HRA biomarker, %n-6 in HUFA [<xref ref-type="bibr" rid="scirp.62148-ref35">35</xref>] . To prepare this snack: break up the pretzels in a small bowl, drizzle the flax oil, and stir to coat. This snack is an alternative to a 1.25oz serving of tree nuts which provide 206 - 231 kcal and much more negative balance scores (<xref ref-type="table" rid="table2">Table 2</xref>). Another functional food combines 4oz low-fat cottage cheese (81 kcal, score = −0.2) with 1 tsp flax oil (40 kcal, score =+46) to give a 121 kcal snack (score = +15). Recipes and meal plans made with Omega Meals can be saved for future</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Balance of n-3 and n-6 fats in tree nuts. The milligrams of n-3 and n-6 essential polyunsaturated acids (PUFA) per ounce of tree nuts. The color code for Balance Scores reflects the likely impact food items will have on the HRA value, % n-6 in HUFA</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Tree Nuts (1 oz)</th><th align="center" valign="middle" >PUFA n-3</th><th align="center" valign="middle" >PUFA n-6</th><th align="center" valign="middle" >BALANCE SCORE</th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >Walnuts</td><td align="center" valign="middle" >2574</td><td align="center" valign="middle" >10,799</td><td align="center" valign="middle" >−44</td><td align="center" valign="middle"  rowspan="10"  ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-2701750x7.png" xlink:type="simple"/></inline-formula></td></tr><tr><td align="center" valign="middle" >Brazil nuts</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >6769</td><td align="center" valign="middle" >−40</td></tr><tr><td align="center" valign="middle" >Peanuts</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4675</td><td align="center" valign="middle" >−28</td></tr><tr><td align="center" valign="middle" >Pecans</td><td align="center" valign="middle" >280</td><td align="center" valign="middle" >5848</td><td align="center" valign="middle" >−28</td></tr><tr><td align="center" valign="middle" >Pistachio</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >3823</td><td align="center" valign="middle" >−23</td></tr><tr><td align="center" valign="middle" >Almonds</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3494</td><td align="center" valign="middle" >−21</td></tr><tr><td align="center" valign="middle" >Cashew nuts</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >2206</td><td align="center" valign="middle" >−14</td></tr><tr><td align="center" valign="middle" >Hazelnuts</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >2221</td><td align="center" valign="middle" >−12</td></tr><tr><td align="center" valign="middle" >Chestnuts</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >125</td><td align="center" valign="middle" >−3</td></tr><tr><td align="center" valign="middle" >Macadamia</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >367</td><td align="center" valign="middle" >−1.5</td></tr></tbody></table></table-wrap><p>use, modified as desired, and printed to share with friends. Every recipe and meal plan displays a chart indicating the likely impact on the predictive HRA biomedical value, the %n-6 in HUFA [<xref ref-type="bibr" rid="scirp.62148-ref35">35</xref>] .</p><p>The top 100 Key Foods for Americans [<xref ref-type="bibr" rid="scirp.62148-ref48">48</xref>] have an average Omega Balance Score near −6 [<xref ref-type="bibr" rid="scirp.62148-ref2">2</xref>] , related to a HRA value of 78% n-6 in HUFA (like common American diets). Removing ten foods with the most negative scores leaves 90 Key Foods with an average Score of -3 and an HRA value of 63% n-6 in HUFA (like traditional Mediterranean diets). Possible alternatives to the removed items are in <xref ref-type="table" rid="table3">Table 3</xref>.</p><p>The top 100 foods do not include seafood which has positive Balance Scores: scallops, +15; shrimp, +29; crab, +30; flounder, +30; mussels, +32; white tuna, +46; sea bass, +49; sardines, +53; striped bass, +55; Coho salmon, +57; Eastern oysters, +57; kippered herring, +70; and canned pink salmon, +83. Also, marine plants are becoming more available to US consumers: kelp, −2; laver, +14; and wakame, +26. The American Heart Association and the American Psychiatric Association recommend eating seafood twice a week. Consumers need help in finding more functional foods with positive scores that lower their %n-6 in HUFA [<xref ref-type="bibr" rid="scirp.62148-ref36">36</xref>] , improve health and quality of life [<xref ref-type="bibr" rid="scirp.62148-ref34">34</xref>] and shift personal finances from treatments to other desired uses [<xref ref-type="bibr" rid="scirp.62148-ref9">9</xref>] .</p><p><xref ref-type="fig" rid="fig2">Figure 2</xref> illustrates an Omega Meals plan that initially had an overall Balance Score of −6.9 with an estimated HRA value of 82% n-6 in HUFA (near typical American values of −6 to −7 and 75% - 80%, respectively). It was altered by replacing turkey (−15.9) with salmon (+52.6) to give an overall Score of +2.3 and a predicted HRA value of 37% n-6 in HUFA (near traditional Japanese levels). This plan can be changed further by replacing walnuts (−44.4) with the pretzel/flax oil snack described above (+24); olive oil (−8.3) with coconut oil (−2.1); and avocado (−10.4) with a glass of wine (0). The overall Balance Score would then be +9.5 with an estimated HRA biochemical outcome of 19% n-6 in HUFA (near traditional Greenland Inuit levels). Existing food items already allow people to make food choices that lower their HUFA balance, and new functional foods and nutraceuticals certainly will make that task much easier. Such new consumer items can positively shift US financial outlays from healthcare treatments to economic development [<xref ref-type="bibr" rid="scirp.62148-ref9">9</xref>] .</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Possible Alternatives for Widely Consumed US Foods. Ten foods from the top 100 Key Food for Americans [<xref ref-type="bibr" rid="scirp.62148-ref48">48</xref>] are shown with their corresponding Balance Scores and possible alternatives. All Scores are based on milligrams of n-3 and n-6 essential polyunsaturated acids (PUFA) per Calorie</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Food with a Very Negative Score</th><th align="center" valign="middle" >Balance Score (per kcal)</th><th align="center" valign="middle" >Possible Alternatives</th><th align="center" valign="middle" >Balance Score (per kcal)</th></tr></thead><tr><td align="center" valign="middle" >Soybean oil</td><td align="center" valign="middle" >−50</td><td align="center" valign="middle" >Olive oil Canola oil High-oleic sunflower oil</td><td align="center" valign="middle" >−8 −12 −4</td></tr><tr><td align="center" valign="middle" >Mayonnaise</td><td align="center" valign="middle" >−46</td><td align="center" valign="middle" >Fat free mayonnaise Mayonnaise with canola or olive oil</td><td align="center" valign="middle" >0 −10</td></tr><tr><td align="center" valign="middle" >Tub margarine</td><td align="center" valign="middle" >−39</td><td align="center" valign="middle" >Butter Coconut oil</td><td align="center" valign="middle" >−1 −2</td></tr><tr><td align="center" valign="middle" >Microwave popcorn</td><td align="center" valign="middle" >−37</td><td align="center" valign="middle" >Low-fat microwave popcorn</td><td align="center" valign="middle" >−7</td></tr><tr><td align="center" valign="middle" >“Italian” dressing</td><td align="center" valign="middle" >−35</td><td align="center" valign="middle" >Fat free “Italian” Lemon and olive oil Flax &amp; olive oil vinaigrette</td><td align="center" valign="middle" >0 −8 +19</td></tr><tr><td align="center" valign="middle" >Potato chips</td><td align="center" valign="middle" >−29</td><td align="center" valign="middle" >Baked potato chips Pretzels with flax oil</td><td align="center" valign="middle" >−8 +24</td></tr><tr><td align="center" valign="middle" >Stick margarine</td><td align="center" valign="middle" >−28</td><td align="center" valign="middle" >Butter</td><td align="center" valign="middle" >−1</td></tr><tr><td align="center" valign="middle" >Vegetable shortening</td><td align="center" valign="middle" >−28</td><td align="center" valign="middle" >Lard Coconut oil</td><td align="center" valign="middle" >−10 −2</td></tr><tr><td align="center" valign="middle" >Peanut butter</td><td align="center" valign="middle" >−24</td><td align="center" valign="middle" >High oleic peanut butter Flax-peanut butter Gouda Cheese</td><td align="center" valign="middle" >−4 +4 +0.4</td></tr><tr><td align="center" valign="middle" >Tortilla chip snacks</td><td align="center" valign="middle" >−22</td><td align="center" valign="middle" >Taco-flavor tortillas Flour tortillas</td><td align="center" valign="middle" >−6 −5</td></tr></tbody></table></table-wrap><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Daily Meal Plan with a Balance Score of +2.3. The meal plan using the Omega Meals tool [<xref ref-type="bibr" rid="scirp.62148-ref35">35</xref>] shows foods eaten at different mealtimes. Highlighting scores by color visually indicates the impact of each food item on the biomedical HRA value, %n-6 in HUFA</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-2701750x8.png"/></fig></sec><sec id="s5"><title>5. Conclusion</title><p>A quantitative empirical relationship describes how dietary n-3 and n-6 essential fatty acids maintain the proportions of n-3 and n-6 in tissue HUFA. Traditional food habits of different populations maintain HUFA balances</p><p>that range from 25% to 85% n-6 in HUFA and associate with the incidence and severity of many different chronic disorders made worse by n-6 eicosanoids. The combined impact of multiple food choices creates HUFA imbalances in Americans. New food choices with more positive omega 3 - 6 balance scores can reverse imbalances. Consumers need new functional foods and nutraceuticals to help them avoid the need to medicate preventable health conditions and to maintain better a quality of life. Tools and apps for making explicit food choices allow individual consumers to arrange balanced food combinations in their homes. In addition, the tools guide food producers and marketers to make balanced combinations available to the many consumers who do not have time to prepare foods at home. The US spends more on treatment of food-based chronic conditions than it does on food. Prevention costs less than treatment. Informed actions using more functional foods and nutraceuticals can shift some of the $2.7T the US spends annually treating chronic conditions toward preventing the need to treat.</p></sec><sec id="s6"><title>Acknowledgements</title><p>Dr. N. Schoene gave helpful advice on this manuscript.</p></sec><sec id="s7"><title>Author Contributions</title><p>Both authors shared in the preparation of the manuscript.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no financial arrangements related to this manuscript. CC is a clinical nutrition consultant and BL is a retired professor of biochemistry.</p></sec><sec id="s9"><title>Cite this paper</title><p>CatharineClark,BillLands, (2015) Creating Benefits from Omega-3 Functional Foods and Nutraceuticals. Food and Nutrition Sciences,06,1613-1623. doi: 10.4236/fns.2015.617166</p></sec></body><back><ref-list><title>References</title><ref id="scirp.62148-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">EFAeducation.org (2015) Relating Diets to Tissue HUFA. http://efaeducation.org/?p=188</mixed-citation></ref><ref id="scirp.62148-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Lands, B. and Lamoreaux, E. (2012) Using 3-6 Differences in Essential Fatty Acids Rather than 3/6 Ratios Gives Useful Food Balance Scores. Nutrition &amp; Metabolism, 9, No. 46.  
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533819/pdf/1743-7075-9-46.pdf  
http://dx.doi.org/10.1186/1743-7075-9-46</mixed-citation></ref><ref id="scirp.62148-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Lands, B. (2011) Prevent the Cause, Not Just the Symptoms. Prostaglandins &amp; Other Lipid Mediators, 96, 90-93. 
http://dx.doi.org/10.1016/j.prostaglandins.2011.07.003</mixed-citation></ref><ref id="scirp.62148-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Lands, B. (2014) Historical Perspectives on the Impact of n-3 and n-6 Nutrients on Health. Progress in Lipid Research, 55, 17-29. http://www.sciencedirect.com/science/article/pii/S0163782714000253  
http://dx.doi.org/10.1016/j.plipres.2014.04.002</mixed-citation></ref><ref id="scirp.62148-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Lands, B. (2015) Omega-3 PUFAs Lower the Propensity for Arachidonic Acid Cascade Overreactions. Biomed Research International, 2015, Article ID 285135. http://www.hindawi.com/journals/bmri/2015/285135/  
http://dx.doi.org/10.1155/2015/285135</mixed-citation></ref><ref id="scirp.62148-ref6"><label>6</label><mixed-citation publication-type="book" xlink:type="simple">Lands, B. (2016) Fatty Acids: Essential Fatty Acids. In: Caballero, B., Finglas, P. and Toldrá, F., Eds., The Encyclopedia of Food and Health, Academic Press, Oxford, Vol. 2, 615-622. 
http://dx.doi.org/10.1016/b978-0-12-384947-2.00279-8</mixed-citation></ref><ref id="scirp.62148-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Ameur, A., Enroth, S., Johansson, A., Zaboli, G., Igl, W., Johansson, A.C.V., Rivas, M.A., Daly, M.J., Schmitz, G., Hicks, A.A., Meitinger, T., Feuk, L., van Duijn, C., Oostra, B., Pramstaller, P.P., Rudan, I., Wright, A.F., Wilson, J.F., Campbell, H. and Gyllensten, A. (2012) Genetic Adaptation of Fatty-Acid Metabolism: A Human-Specific Haplotype Increasing the Biosynthesis of Long-Chain Omega-3 and Omega-6 Fatty Acids. The American Journal of Human Genetics, 90, 809-820. http://dx.doi.org/10.1016/j.ajhg.2012.03.014</mixed-citation></ref><ref id="scirp.62148-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Centers for Disease Control and Prevention (CDC) (2015) Minority Health.  
http://www.cdc.gov/minorityhealth/populations/REMP/black.html</mixed-citation></ref><ref id="scirp.62148-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Clark, C. and Lands, B. (2016) What Financial Motivations Support Preventive Nutrition? Nutrition and Health, Unpublished.</mixed-citation></ref><ref id="scirp.62148-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Centers for Disease Control and Prevention (2015) Chronic Disease Overview.  
http://www.cdc.gov/chronicdisease/overview/</mixed-citation></ref><ref id="scirp.62148-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Gerteis, J., Izrael, D., Deitz, D., LeRoy, L., Ricciardi, R., Miller, T. and Basu, J., Agency for Healthcare Research and Quality (AHRQ) (2014) Multiple Chronic Conditions Chartbook.  
http://www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/mccchartbook.pdf</mixed-citation></ref><ref id="scirp.62148-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Health Spending Explorer (2015) Peterson-Kaiser Health System Tracker.  
http://www.healthsystemtracker.org/interactive/health-spending-explorer/?display=U.S.%2520%2524%2520Billions&amp;service=Hospitals%252CPhysicians%2520%2526%2520Clinics%252CPrescription%2520Drug</mixed-citation></ref><ref id="scirp.62148-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Keehan, S.P., Cuckler, G.A., Sisko, A.M., Madison, A.J., Smith, S.D., Stone, D.A., Poisal, J.A., Wolfe, C.J. and Lizonitz, J.M. (2015) National Health Expenditure Projections, 2014-24: Spending Growth Faster than Recent Trends. Health Affairs, 8, 1707-1717. (Exhibit 3)</mixed-citation></ref><ref id="scirp.62148-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Kaiser Family Foundation (2012) Health Care Costs: A Primer. (Figure 1)  
http://kff.org/report-section/health-care-costs-a-primer-2012-report/</mixed-citation></ref><ref id="scirp.62148-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Fries, J.F., Koop, C.E., Sokolov, J., Beadle, C.E. and Wright, D. (1998) Beyond Health Promotion: Reducing Need and Demand for Medical Care. Health Affairs, 17, 70-84. http://dx.doi.org/10.1377/hlthaff.17.2.70</mixed-citation></ref><ref id="scirp.62148-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Centers for Disease Control and Prevention (CDC) (2009) The Power of Prevention Chronic Disease . . . the Public Health Challenge of the 21st Century. http://www.cdc.gov/chronicdisease/pdf/2009-Power-of-Prevention.pdf</mixed-citation></ref><ref id="scirp.62148-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Hibbeln, J.R. and Davis, J.M. (2009) Considerations Regarding Neuropsychiatric Nutritional Requirements for Intakes of Mmega-3 Highly Unsaturated Fatty Acids. Prostaglandins, Leukotrienes and Essential Fatty Acids, 81, 179-186. 
http://dx.doi.org/10.1016/j.plefa.2009.06.005</mixed-citation></ref><ref id="scirp.62148-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Centers for Disease Control and Prevention (CDC) (2015) Chronic Obstructive Pulmonary Disease.  
http://www.cdc.gov/copd/index.html</mixed-citation></ref><ref id="scirp.62148-ref19"><label>19</label><mixed-citation publication-type="book" xlink:type="simple">Lands, B. (2016) Omega-3 Fatty Acids Counterbalance Actions of Omega-6 Fatty Acids. In: Raatz, S. and Bibus, D., Eds., Fish and Fish Oils in Health and Disease, Elsevier, Philadelphia</mixed-citation></ref><ref id="scirp.62148-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Murphy, R.C., Pickett, W.C., Culp, B.R and Lands, W.E.M. (1981) Tetraene and Pentaene Leukotrienes: Selective Production from Murine Mastocytoma Cells after Dietary Manipulation. Prostaglandins, 22, 613-622. 
http://dx.doi.org/10.1016/0090-6980(81)90070-8</mixed-citation></ref><ref id="scirp.62148-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Soderstrom, M., Mannervik, B., Garkov, V. and Hammarstrom, S. (1992) On the Nature of Leukotriene C4 Synthase in Human Platelets. Archives of Biochemistry and Biophysics, 294, 70-74. 
http://dx.doi.org/10.1016/0003-9861(92)90138-M</mixed-citation></ref><ref id="scirp.62148-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Lee, T.H., Sethi, T., Crea, A.E.G., Peters, W., Arm, J.P., Horton, C.E., Walport, M.J. and Spur, B.W. (1988) Characterization of Leukotriene B3: Comparison of its Biological Activities with Leukotriene B4 and Leukotriene B5 in Complement Receptor Enhancement, Lysozyme Release and Chemotaxis of Human Neutrophils. Clinical Science, 74, 467-475. http://dx.doi.org/10.1042/cs0740467</mixed-citation></ref><ref id="scirp.62148-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Mohanan, S., Horibata, S., McElwee, J.L., Dannenberg, A.J. and Coonrod, S.A. (2013) Identification of Macrophage Extracellular Trap-like Structures in Mammary Gland Adipose Tissue: a Preliminary Study. Frontiers in Immunology, 4, 1-8. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600535/  
http://dx.doi.org/10.3389/fimmu.2013.00067</mixed-citation></ref><ref id="scirp.62148-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Li, P., Oh, D.Y., Bandyopadhyay, G., Lagakos, W.S., Talukdar, S., Osborn, O., Johnson, A., Chung, H., Mayoral, R., Maris, M., Ofrecio, J.M., Taguchi, S., Lu, M. and Olefsky, J.M. (2015) LTB4 Promotes Insulin Resistance in Obese Mice by Acting on Macrophages, Hepatocytes and Myocytes. Nature Medicine, 21, 239-247. 
http://dx.doi.org/10.1038/nm.3800</mixed-citation></ref><ref id="scirp.62148-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Spite, M., Hellmann, J., Tang, Y., Mathis, S.P., Kosuri, M., Bhatnagar, A., Jala, V.R. and Haribabu, B. (2011) Deficiency of the Leukotriene B4 Receptor, BLT-1, Protects against Systemic Insulin Resistance in Diet-induced Obesity. The Journal of Immunology, 187, 1942-1949. http://dx.doi.org/10.4049/jimmunol.1100196</mixed-citation></ref><ref id="scirp.62148-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Alvheim, A.R., Malde, M.K., Osei-Hyiaman, D., Lin, Y.H., Pawlosky, R.L., Madsen, L., Kristiansen, K., Fr&amp;oslash;yland, L. and Hibbeln, J.R. (2012) Dietary Linoleic Acid Elevates Endocannabinoids 2-AG and Anandamide and Induces Obesity. Obesity, 10, 1984-1994. http://dx.doi.org/10.1038/oby.2012.38</mixed-citation></ref><ref id="scirp.62148-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Alvheim A.R., Torstensen B.E., Lin Y.H., Lillefosse H.H., Lock E.J., Madsen L., Fr&amp;oslash;yland L., Hibbeln J.R. and Malde M.K. (2014) Dietary Linoleic Acid Elevates the Endocannabinoids 2-AG and Anandamide and Promotes Weight Gain in Mice Fed a Low Fat Diet. Lipids, 49, 59-69. http://dx.doi.org/10.1007/s11745-013-3842-y</mixed-citation></ref><ref id="scirp.62148-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Alvheim, A.R., Torstensen, B.E., Lin, Y.H., Lillefosse, H.H., Lock, E.J., Madsen, L., Hibbeln, J.R. and Malde, M.K. (2013) Dietary Linoleic Acid Elevates Endogenous 2-Arachidonoylglycerol and Anandamide in Atlantic Salmon (Salmo salar L.) and Mice, and Induces Weight Gain and Inflammation in Mice. British Journal of Nutrition, 109, 1508-1517. http://dx.doi.org/10.1017/S0007114512003364</mixed-citation></ref><ref id="scirp.62148-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">The Look AHEAD Research Group, Wing, R.R., Bolin, P., Brancati, F.L., Bray, G.A., Clark, J.M., Coday, M., Crow, R.S., Curtis, J.M., Egan, C.M., Espeland, M.A., Evans, M., Foreyt, J.P., Ghazarian, S., Gregg, E.W., Harrison, B., Hazuda, H.P., Hill, J.O., Horton, E.S., Hubbard, V.S., Jakicic, J.M., Jeffery, R.W., Johnson, K.C., Kahn, S.E., Kitabchi, A.E., Knowler, W.C., Lewis, C.E., Maschak-Carey, B.J., Montez, M.G., Murillo, A., Nathan, D.M., Patricio, J., Peters, A., Pi-Sunyer, X., Pownall, H., Reboussin, D., Regensteiner, J.G., Rickman, A.D., Ryan, D.H., Safford, M., Wadden, T.A., Wagenknecht, L.E., West, D.S., Williamson, D.F. and Yanovski, S.Z. (2013) Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes. The New England Journal of Medicine, 369, 145-154.  
http://dx.doi.org/10.1056/NEJMoa1212914</mixed-citation></ref><ref id="scirp.62148-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Lands, W.E.M. (2003) Diets Could Prevent Many Diseases. Lipids, 38, 317-321. 
http://dx.doi.org/10.1007/s11745-003-1066-0</mixed-citation></ref><ref id="scirp.62148-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Marugame, T. and Mizuno, S. (2005) Comparison of Prostate Cancer Mortality in Five Countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960-2000). Japanese Journal of Clinical Oncology, 35, 690-691. 
http://dx.doi.org/10.1093/jjco/hyi185</mixed-citation></ref><ref id="scirp.62148-ref32"><label>32</label><mixed-citation publication-type="book" xlink:type="simple">Howlader, N., Noone, A.M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S.F., Kosary, C.L., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D.R., Chen, H.S., Feuer, E.J. and Cronin, K.A., Eds. (2015) Prostate Cancer: Cancer Statistics Review, 1975-2012, National Cancer Institute. http://seer.cancer.gov/statfacts/html/prost.html</mixed-citation></ref><ref id="scirp.62148-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Huang, R.Y., Li, S.S., Guo, H.Z., Huang, Y., Zhang, X., Li, M.Y., Chen, G.G. and Zeng, X. (2014) Thromboxane A2 Exerts Promoting Effects on Cell Proliferation Through Mediating Cyclooxygenase-2 Signal in Lung Adenocarcinoma Cells. Journal of Cancer Research and Clinical Oncology, 140, 375-386. http://dx.doi.org/10.1007/s00432-013-1573-3</mixed-citation></ref><ref id="scirp.62148-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Ramsden, C.E., Faurot, K.R., Zamora, D., Suchindran, C.M., MacIntosh, B.A., Gaylord, S., Ringel, A., Hibbeln, J.R., Feldstein, A.E., Mori, T.A., Barden, A., Lynch, C., Coble, R., Mas, E., Palsson, O., Barrow, D.A. and Mann, J.D. (2013) Targeted Alteration of Dietary n-3 and n-6 Fatty Acids for the Treatment of Chronic Headaches: A Randomized Trial. Pain, 154, 2441-2451. http://dx.doi.org/10.1016/j.pain.2013.07.028</mixed-citation></ref><ref id="scirp.62148-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">EFAeducation.org (2015) Omega 3-6 Apps Use Balance Scores. http://efaeducation.org/omega-3-6-apps/</mixed-citation></ref><ref id="scirp.62148-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Bibus, D. and Lands, B. (2015) Balancing Proportions of Competing Omega-3 and Omega-6 Highly Unsaturated Fatty Acids (HUFA) in Tissue Lipids. Prostaglandins LeukotEssent Fatty Acids, 99, 19-23.  
http://www.plefa.com/article/S0952-3278(15)00087-3/pdf  
http://dx.doi.org/10.1016/j.plefa.2015.04.005</mixed-citation></ref><ref id="scirp.62148-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Ramsden, C.E., Faurot, K.R., Zamora, D., Palsson, O.S., MacIntosh, B.A., Gaylord, S., Taha, A.Y., Rapoport, S.I., Hibbeln, J.R., Davis, J.M. and Mann, J,D. (2015) Targeted Alterations in Dietary n-3 and n-6 Fatty Acids Improve Life Functioning and Reduce Psychological Distress among Patients with Chronic Headache: A Secondary Analysis of a Randomized Trial. Pain, 156, 587-596. http://dx.doi.org/10.1097/01.j.pain.0000460348.84965.47</mixed-citation></ref><ref id="scirp.62148-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">MacIntosh, B.A., Ramsden, C.E., Faurot, K.R., Zamora, D., Mangan, M., Hibbeln, J.R. and Mann, J.D. (2013) Low-n-6 and Low-n-6 Plus High-n-3 Diets for Use in Clinical Research. British Journal of Nutrition, 110, 559-568. 
http://dx.doi.org/10.1017/S0007114512005181</mixed-citation></ref><ref id="scirp.62148-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Wood, K.E., Mantzioris, E., Gibson, R.A. and Muhlhausler, B.S. (2013) Incorporating Macadamia Oil and Butter to Reduce Dietary Omega-6 Polyunsaturated Fatty Acid Intake. Nutrition &amp; Dietetics, 70, 94-100. 
http://dx.doi.org/10.1111/j.1747-0080.2012.01636.x</mixed-citation></ref><ref id="scirp.62148-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">U.S. Department of Defense (2013) Defense Science Board Study on Technology Innovation Enablers for Superiority in 2030. 80-83. http://www.acq.osd.mil/dsb/reports/DSB2030.pdf</mixed-citation></ref><ref id="scirp.62148-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Marriott, B.P., Yu, K., Majchrzak-Hong, S., Johnson, J. and Hibbeln, J.R. (2014) Understanding Diet and Modeling Changes in the Omega-3 and Omega-6 Fatty Acid Composition of U.S. Garrison Foods for Active Duty Personnel. Military Medicine, 179, 168-175. http://dx.doi.org/10.7205/MILMED-D-14-00199</mixed-citation></ref><ref id="scirp.62148-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Lin, Y.H., Hanson, J.A., Strandjord, S.E., Salem, N.M., Dretsch, M.N., Haub, M.D. and Hibbeln, J.R. (2014) Fast Transmethylation of Total Lipids in Dried Blood by Microwave Irradiation and Its Application to a Population Study. Lipids, 49, 839-851. http://dx.doi.org/10.1007/s11745-014-3918-3</mixed-citation></ref><ref id="scirp.62148-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">DuPont Pioneer (2015) Plenish&amp;reg; High Oleic Soybeans  
https://www.pioneer.com/home/site/us/products/soybean/enhanced-oil-soybeans/</mixed-citation></ref><ref id="scirp.62148-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Branch, W.D. (2014) Registration of “Georgia-13M” Peanut. Journal of Plant Registrations, 8, 253-256.  
http://dx.doi.org/10.3198/jpr2013.11.0071crc</mixed-citation></ref><ref id="scirp.62148-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Gorbet, D. (2003) SunOleic&amp;reg;/High Oleic Peanuts: A Step Forward.  
http://ufdcimages.uflib.ufl.edu/IR/00/00/15/85/00001/AG15900.pdf</mixed-citation></ref><ref id="scirp.62148-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Isleib, T.G., Pattee, H.E., Sanders, T.H., Hendrix, K.W. and Dean, L.O. (2006) Compositional and Sensory Comparisons between Normal- and High-Oleic Peanuts. Journal of Agricultural and Food Chemistry, 54, 1759-1763. 
http://dx.doi.org/10.1021/jf052353t</mixed-citation></ref><ref id="scirp.62148-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Derbyshire, E.J. (2014) A Review of the Nutritional Composition, Organoleptic Characteristics and Biological Effects of the High Oleic Peanut. International Journal of Food Sciences and Nutrition, 65, 781-790. 
http://dx.doi.org/10.3109/09637486.2014.937799</mixed-citation></ref><ref id="scirp.62148-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Haytowitz, D.B. (2012) List of Key Foods Based on NHANES 2007-08.  
http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/KeyFoods/Keyfoods_0708.xlsx</mixed-citation></ref></ref-list></back></article>